After CAG25 treatment, the DM1 myotubes derived from Pt-3 showed elevation of DMD exon 78 and BIN1 exon 11 inclusions in a dose-dependent manner (Supplementary Fig. S7a–c). This evidence concerns the gene DMD and myotonic dystrophy type 1.